Regulatory & Legal
BSE India11 Sept 2026, 5:30 am IST
Sun Pharma subsidiaries settle US antitrust claim
What happened
- Subsidiaries of Sun Pharma settled a claim from a U.S. antitrust plaintiff.
- The settlement amount is confidential.
Key terms explained
Financial terms from this story, in everyday words.
- Antitrust
- Laws designed to prevent unfair business practices and monopolies.
Original source
BSE India
Was this summary clear?
For information only — not investment advice.Summarized automatically; always check the original before acting.